Investigating cell therapies in animal models of Parkinson’s and Huntington’s disease: Current challenges and considerations

Investigating cell therapies in animal models of Parkinson’s and Huntington’s disease: Current challenges and considerations
Int Rev Neurobiol. 2022;166:159-189. doi: 10.1016/bs.irn.2022.09.005. Epub 2022 Oct 8.ABSTRACTCell therapeutics have entered into an exciting era, with first-in-person clinical trials underway for Parkinson's disease and novel cell therapies in development for other neurodegenerative diseases. In the hope of ensuring successful translation of these novel cell products to the clinic, a significant amount of preclinical work continues to be undertaken. ... read more
Source: PubMedPublished on 2022-11-24By Mariah J Lelos